Product Details
Product Name:
KL1333 |
CAS No.:
1800405-30-4 |
Purity:
99.27% |
Supply Ability:
10g |
Release date:
2024/11/11 |
Product Introduction
Bioactivity
名稱 | KL1333 |
描述 | KL1333 (NQO1 activator 1) enhances energy metabolism and mitochondrial dysfunction in MELAS fibroblasts. Elevated NAD+ levels trigger the activation of SIRT1 and AMPK, and subsequently activates PGC-1α. NQO1 activator 1 is an orally available NAD+ modulator. It reacts with NAD(P)H: NQO1 as a substrate, resulting in increases in intracellular NAD+ levels via NADH oxidation. |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 245 mg/mL (1019.73 mM), Sonication is recommended.
|
關(guān)鍵字 | Mitochondrial Metabolism | Inhibitor | KL1333 | KL-1333 | inhibit | KL 1333 |
相關(guān)產(chǎn)品 | Imeglimin hydrochloride | Rotenone | Metronidazole | Resveratrol | Pasiniazid | Boscalid | α-Lipoic Acid | NAD+ | Lipoic acid | Apocynin | D-Histidine | Nerol |
相關(guān)庫 | 銅死亡化合物庫 | 經(jīng)典已知活性庫 | 藥物功能重定位化合物庫 | 線粒體靶向庫 | 代謝化合物庫 | 口服活性化合物庫 | 抗衰老化合物庫 | 臨床期小分子藥物庫 | 已知活性化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
CAS:362003-83-6
$54.00 / 5mg
-
CAS:219311-44-1
$53.00 / 1mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |